Two research areas. A shared molecular design approach
Our science connects innate immune signaling and regenerative peptide biology through computational molecular design and experimental validation.
Innate Immune Signaling Modulation
We investigate both inhibition and activation, with the direction of modulation determined by each program's biological objective.
ETI41 and ETI60 are investigated primarily against endosomal TLR3, TLR7 and TLR9 signaling, with relatively weaker activity against TLR8. ETA53 focuses on TLR9 inhibition following myocardial infarction.
ATA2 takes a different approach: this DNA aptamer activates TLR9 signaling and is studied in cellular systems for potential immune-modulating applications.
Regenerative Peptide Therapeutics
Selected receptor-directed signals may influence cell migration, proliferation, angiogenesis and tissue repair.
FAP1
FGF-mimetic peptide investigated in wound repair.
VMP3
VEGF-mimetic peptide investigated in angiogenesis and wound models.
SDP-4
SDF-1α-mimetic peptide investigated in endogenous cell recruitment.
SP1
Substance P analog investigated in cell migration and recruitment.
Recruiting the body's own repair resources
Endogenous stem cell recruitment is a central mechanism under investigation in the SDP-4 and SP1 programs.
Studies tracking externally administered cells address a different question. We distinguish exogenous cell migration from evidence that endogenous cells have been recruited.
Design · Evaluate · Refine
Computational analysis of target-ligand interactions guides candidate design. Experimental assessment then characterizes biological activity and informs further refinement.
Read selected publications